ELN and neoplasm: In terms of antitumor efficacy, significant tumor-volume reductions and good tolerability have been documented for elastin-like systems with doxorubicin and for modulated electro-hyperthermia approaches, with no added cardiotoxicity when thermal dosimetry is properly controlled [3,4].